Martingale Asset Management’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $385K | Buy |
+13,010
| New | +$385K | 0.01% | 664 |
|
|
2025
Q1 | – | Sell |
-29,087
| Closed | -$833K | – | 783 |
|
|
2024
Q4 | $833K | Sell |
29,087
-10,700
| -27% | -$307K | 0.02% | 517 |
|
|
2024
Q3 | $1.54M | Buy |
39,787
+291
| +0.7% | +$11.2K | 0.04% | 371 |
|
|
2024
Q2 | $1.27M | Sell |
39,496
-100
| -0.3% | -$3.22K | 0.03% | 397 |
|
|
2024
Q1 | $1.54M | Buy |
39,596
+107
| +0.3% | +$4.15K | 0.03% | 358 |
|
|
2023
Q4 | $1.22M | Buy |
39,489
+464
| +1% | +$14.3K | 0.02% | 408 |
|
|
2023
Q3 | $872K | Buy |
39,025
+400
| +1% | +$8.94K | 0.02% | 475 |
|
|
2023
Q2 | $830K | Buy |
38,625
+4,401
| +13% | +$94.6K | 0.02% | 494 |
|
|
2023
Q1 | $821K | Buy |
34,224
+6,056
| +21% | +$145K | 0.02% | 500 |
|
|
2022
Q4 | $653K | Buy |
28,168
+3,855
| +16% | +$89.4K | 0.01% | 571 |
|
|
2022
Q3 | $390K | Buy |
24,313
+7,887
| +48% | +$127K | 0.01% | 667 |
|
|
2022
Q2 | $292K | Buy |
16,426
+393
| +2% | +$6.99K | 0.01% | 737 |
|
|
2022
Q1 | $327K | Buy |
+16,033
| New | +$327K | ﹤0.01% | 713 |
|
|
2021
Q3 | – | Sell |
-10,014
| Closed | -$237K | – | 863 |
|
|
2021
Q2 | $237K | Sell |
10,014
-6,616
| -40% | -$157K | ﹤0.01% | 770 |
|
|
2021
Q1 | $396K | Sell |
16,630
-300
| -2% | -$7.14K | ﹤0.01% | 675 |
|
|
2020
Q4 | $341K | Sell |
16,930
-59,288
| -78% | -$1.19M | ﹤0.01% | 715 |
|
|
2020
Q3 | $1.59M | Buy |
76,218
+44,914
| +143% | +$936K | 0.02% | 489 |
|
|
2020
Q2 | $548K | Sell |
31,304
-33
| -0.1% | -$578 | 0.01% | 860 |
|
|
2020
Q1 | $512K | Buy |
+31,337
| New | +$512K | 0.01% | 809 |
|
|
2019
Q4 | – | Sell |
-95,965
| Closed | -$1.1M | – | 973 |
|
|
2019
Q3 | $1.1M | Buy |
+95,965
| New | +$1.1M | 0.01% | 747 |
|
|
2019
Q2 | – | Sell |
-58,544
| Closed | -$888K | – | 1015 |
|
|
2019
Q1 | $888K | Buy |
58,544
+711
| +1% | +$10.8K | 0.01% | 805 |
|
|
2018
Q4 | $994K | Buy |
+57,833
| New | +$994K | 0.01% | 721 |
|